Gain Therapeutics, Inc. - stock earnings
GANX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -4.7 million USD | ? USD |
| 2023Q2 | -7.7 million USD | ? USD |
| 2023Q1 | -5.1 million USD | 55180 USD |
| 2022Q4 | -4.7 million USD | 140108 USD |
| 2022Q3 | -4.6 million USD | ? USD |
| 2022Q2 | -5.1 million USD | 95102 USD |
| 2022Q1 | -3.3 million USD | 45006 USD |
| 2021Q4 | -3.2 million USD | 36341 USD |
| 2021Q3 | -4.7 million USD | 27345 USD |
| 2021Q2 | -3.6 million USD | 89173 USD |
| 2021Q1 | -2.5 million USD | 5269 USD |
| 2020Q4 | -1.7 million USD | 9139 USD |
| 2020Q3 | -794371 USD | 6696 USD |
| 2020Q2 | -543362 USD | 6373 USD |
| 2020Q1 | -584268 USD | 6673 USD |
| 2019Q3 | -548361 USD | 10325 USD |
| 2019Q2 | -548361 USD | 10325 USD |
| 2019Q1 | -548361 USD | 10325 USD |
| 2018Q4 | -548361 USD | 10325 USD |
| 2018Q3 | -276385 USD | 5152 USD |
| 2018Q2 | -276385 USD | 5152 USD |
| 2018Q1 | -276385 USD | 5152 USD |
| 2017Q4 | -276385 USD | 5152 USD |
GANX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -22.2 million USD | 55180 USD |
| 2022 | -17.6 million USD | 140108 USD |
| 2021 | -13.9 million USD | 164994 USD |
| 2020 | -3.6 million USD | 28881 USD |
| 2019 | -2.2 million USD | 41301 USD |
| 2018 | -1.1 million USD | 20609 USD |
GANX
Price: $2.96
52 week price:
Earnings Per Share: -1.71 USD
P/E Ratio: -2.65
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 17900
Market Capitalization: 48.0 million